PrEP study for pregnant women in Kenya
Part of Immune system & allergy, Infections clinical trials.
This study aims to expand access to PrEP (a daily pill that prevents HIV) for pregnant and postpartum women visiting maternal and child health clinics in Kenya. It also includes health care workers who provide PrEP services.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a pregnant or postpartum woman visiting a participating clinic in Kenya.
- You are 15 years or older (including emancipated minors).
- You are seeking health services at one of the study facilities.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well a daily pill called PrEP can prevent HIV in pregnant women and their babies. It aims to make sure these women get the support they need to stay healthy.
This study tests a program to help women at risk for HIV stay healthy while planning or having children. It provides prevention tools and support to reduce the chance of getting HIV.
This study offers different forms of HIV prevention medicine (PrEP) to young women ages 18–30 who are visiting clinics for reproductive health services like family planning or postnatal care. It aims to see which delivery method works best for you.
This study looks at whether young women can get PrEP, a daily pill that prevents HIV, from local pharmacies instead of clinics. It aims to make it easier for adolescent girls and young women to start and continue PrEP in selected areas of Tanzania.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study looks at ways to improve PrEP (pre-exposure prophylaxis) care by helping clinic staff track and support patients better. It's for healthcare workers, managers, and data staff at certain PrEP clinics.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.